Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$107.35
+0.32%
Mkt Cap $13.07B
EPS — Estimate vs Actual
Mkt Cap
$13.07B
P/E
43.11
Fwd P/E
7.47
P/S
9.36
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$107.35
+0.32%
Mkt Cap $13.07B
Mkt Cap
$13.07B
P/E
43.11
Fwd P/E
7.47
P/S
9.36
Rev TTM
—
EPS TTM
$2.49